Molecule Details
| InChIKey | CSHPNTOXXBGLLQ-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-cyclohexyl-2-N-[2-(1-methylimidazol-4-yl)ethyl]piperazine-1,2-dicarboxamide |
| Canonical SMILES | Cn1cnc(CCNC(=O)C2CN(C3c4ccc(Cl)cc4CCc4cc(Br)cnc43)CCN2C(=O)NC2CCCCC2)c1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.45 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile